These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 8625762)

  • 21. Kininogen-derived fluorogenic substrates for investigating the vasoactive properties of rat tissue kallikreins--identification of a T-kinin-releasing rat kallikrein.
    El Moujahed A; Brillard-Bourdet M; Juliano MA; Moreau T; Chagas JR; Gutman N; Prado ES; Gauthier F
    Eur J Biochem; 1997 Jul; 247(2):652-8. PubMed ID: 9266709
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Low-salt diet downregulates plasma but not tissue kallikrein-kinin system.
    Hilgenfeldt U; Puschner T; Riester U; Finsterle J; Hilgenfeldt J; Ritz E
    Am J Physiol; 1998 Jul; 275(1):F88-93. PubMed ID: 9689009
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [A role of kallikrein-kinin system in gut diseases].
    Zelawski W; Witalińska-Labuzek J; Stadnicki A
    Wiad Lek; 2005; 58(5-6):331-4. PubMed ID: 16238127
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Eicosanoid regulation of acute intestinal vascular permeability induced by intravenous peptidoglycan-polysaccharide polymers.
    Woolverton CJ; White JJ; Sartor RB
    Agents Actions; 1989 Mar; 26(3-4):301-9. PubMed ID: 2660498
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Resveratrol has antiinflammatory and antifibrotic effects in the peptidoglycan-polysaccharide rat model of Crohn's disease.
    Rahal K; Schmiedlin-Ren P; Adler J; Dhanani M; Sultani V; Rittershaus AC; Reingold L; Zhu J; McKenna BJ; Christman GM; Zimmermann EM
    Inflamm Bowel Dis; 2012 Apr; 18(4):613-23. PubMed ID: 22431488
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Role of kallikrein-kinin system in the pathogenesis of bacterial cell wall-induced inflammation and enterocolitis.
    DeLa Cadena RA; Sartor RB; Adam A; Raymond B; Legris F; Colman RW
    Trans Assoc Am Physicians; 1992; 105():229-37. PubMed ID: 1309001
    [No Abstract]   [Full Text] [Related]  

  • 27. [Kallikrein-kinin system in acute empyema of pleura and pyopneumothorax].
    Tseĭmakh EA; Kurasov VN
    Khirurgiia (Mosk); 1999; (7):40-2. PubMed ID: 10459186
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Streptokinase-induced activation of the kallikrein-kinin system and of the contact phase in patients with acute myocardial infarction.
    Hoffmeister HM; Ruf M; Wendel HP; Heller W; Seipel L
    J Cardiovasc Pharmacol; 1998 May; 31(5):764-72. PubMed ID: 9593077
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of Neurotropin on the activation of the plasma kallikrein-kinin system.
    Nishikawa K; Reddigari SR; Silverberg M; Kuna PB; Yago H; Nagaki Y; Toyomaki Y; Suehiro S; Kaplan AP
    Biochem Pharmacol; 1992 Mar; 43(6):1361-9. PubMed ID: 1562287
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Kallikrein-kinin system in inflammatory bowel diseases: Intestinal involvement and correlation with the degree of tissue inflammation.
    Devani M; Vecchi M; Ferrero S; Avesani EC; Arizzi C; Chao L; Colman RW; Cugno M
    Dig Liver Dis; 2005 Sep; 37(9):665-73. PubMed ID: 15949977
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Modulation of inflammation by kininogen deficiency in a rat model of inflammatory arthritis.
    Sainz IM; Isordia-Salas I; Castaneda JL; Agelan A; Liu B; DeLa Cadena RA; Pixley RA; Adam A; Sartor RB; Colman RW
    Arthritis Rheum; 2005 Aug; 52(8):2549-52. PubMed ID: 16059911
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Selective kallikrein inhibitors alter human neutrophil elastase release during extracorporeal circulation.
    Wachtfogel YT; Hack CE; Nuijens JH; Kettner C; Reilly TM; Knabb RM; Bischoff R; Tschesche H; Wenzel H; Kucich U
    Am J Physiol; 1995 Mar; 268(3 Pt 2):H1352-7. PubMed ID: 7535008
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Identification and characterization of the plasma kallikrein-kinin system inhibitor, haemaphysalin, from hard tick, Haemaphysalis longicornis.
    Kato N; Iwanaga S; Okayama T; Isawa H; Yuda M; Chinzei Y
    Thromb Haemost; 2005 Feb; 93(2):359-67. PubMed ID: 15711755
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Kallikrein-kinin system activation in Crohn's disease: differences in intestinal and systemic markers.
    Devani M; Cugno M; Vecchi M; Ferrero S; Di Berardino F; Avesani EC; de Franchis R; Colman RW
    Am J Gastroenterol; 2002 Aug; 97(8):2026-32. PubMed ID: 12190172
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of a highly selective plasma kallikrein inhibitor on collagen-induced arthritis in mice.
    Fujimori Y; Nakamura T; Shimizu K; Yamamuro T; Wanaka K; Okamoto S; Katsuura Y
    Agents Actions; 1993 May; 39(1-2):42-8. PubMed ID: 8285139
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Anti-tumor necrosis factor α prevents bowel fibrosis assessed by messenger RNA, histology, and magnetization transfer MRI in rats with Crohn's disease.
    Adler J; Rahal K; Swanson SD; Schmiedlin-Ren P; Rittershaus AC; Reingold LJ; Brudi JS; Shealy D; Cai A; McKenna BJ; Zimmermann EM
    Inflamm Bowel Dis; 2013; 19(4):683-90. PubMed ID: 23429466
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tissue interleukin 1 and interleukin-1 receptor antagonist expression in enterocolitis in resistant and susceptible rats.
    McCall RD; Haskill S; Zimmermann EM; Lund PK; Thompson RC; Sartor RB
    Gastroenterology; 1994 Apr; 106(4):960-72. PubMed ID: 8144001
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Increased kallikrein activity in the rabbit renal vasculature during low sodium intake.
    Kuo JJ; Zimmerman BG
    Clin Exp Pharmacol Physiol; 1997 Feb; 24(2):153-6. PubMed ID: 9075588
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacological characterization of rabbit corpus cavernosum relaxation mediated by the tissue kallikrein-kinin system.
    Lopes-Martins RA; Antunes E; Oliva ML; Sampaio CA; Burton J; de Nucci G
    Br J Pharmacol; 1994 Sep; 113(1):81-6. PubMed ID: 7529116
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The kallikrein-kinin system: current and future pharmacological targets.
    Moreau ME; Garbacki N; Molinaro G; Brown NJ; Marceau F; Adam A
    J Pharmacol Sci; 2005 Sep; 99(1):6-38. PubMed ID: 16177542
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.